The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment

Background. The elderly, commonly defined as subjects aged ≥65 years, are among the at-risk subjects recommended for annual influenza vaccination in European countries. Currently, two new vaccines are available for this population: the MF59-adjuvanted quadrivalent influenza vaccine (aQIV) and the hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrò, Giovanna Elisa, Boccalini, Sara, Panatto, Donatella, Rizzo, Caterina, Di Pietro, Maria Luisa, Abreha, Fasika Molla, Ajelli, Marco, Amicizia, Daniela, Bechini, Angela, Giacchetta, Irene, Lai, Piero Luigi, Merler, Stefano, Primieri, Chiara, Trentini, Filippo, Violi, Sara, Bonanni, Paolo, de Waure, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998177/
https://www.ncbi.nlm.nih.gov/pubmed/35409848
http://dx.doi.org/10.3390/ijerph19074166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998177/
https://www.ncbi.nlm.nih.gov/pubmed/35409848
http://dx.doi.org/10.3390/ijerph19074166

Ejemplares similares